Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

61.81
Delayed Data
As of 4:01pm ET
 -0.72 / -1.15%
Today’s Change
47.97
Today|||52-Week Range
65.46
+4.99%
Year-to-Date
Roffman Miller Associates Inc Buys Alphabet Inc, Under Armour Inc, Merck & Co Inc, S...
1:39pm / GuruFocus News - Paid Partner Content
Better Buy: Merck & Co. Inc. vs. Pfizer
Jan 22 / MotleyFool.com - Paid Partner Content
Can Q4 Earnings Revitalize Healthcare ETFs?
11:40am / Zacks.com - Paid Partner Content
US Market Indexes Lower for the Week
Jan 21 / GuruFocus News - Paid Partner Content
Prima Biomed Initiates Randomized Study for Breast Cancer
9:05am / Zacks.com - Paid Partner Content
5 Drugs That Are Way Cheaper in Canada
Jan 21 / MotleyFool.com - Paid Partner Content
Is It Time to Buy Beaten-Down Bristol-Myers Squibb Stock?
8:16am / TheStreet.com - Paid Partner Content
Liberty Capital Management, Inc. Buys Apple Inc, Alphabet Inc, Celgene Corp, Sells Fo...
Jan 20 / GuruFocus News - Paid Partner Content
Bristol Myers-Squibb, Merck, Synergy Pharmaceuticals: Doug Kass' Views
1:06am / TheStreet.com - Paid Partner Content
Why Bristol-Myers Squibb Co Stock Is Slipping Today
Jan 20 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close62.53
Today’s open61.81
Day’s range61.63 - 62.40
Volume10,064,889
Average volume (3 months)11,150,018
Market cap$172.4B
Dividend yield3.04%
Data as of 4:01pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+5.27%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-7.92%
P/E ratio31.5
Price/Sales3.87
Price/Book3.89

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.51-0.72%
PFEPfizer-0.31-0.98%
SNYSanofi-0.14-0.35%
ABBVAbbVie-0.19-0.31%
Data as of 4:02pm ET, 01/23/2017

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$0.88
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts


Search for Jobs